Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5116 to 5130 of 8314 results

  1. Interventions for coordination and delivery of care to improve access and uptake:- What models for the coordination and delivery of care for people in contact with the criminal justice system provide for the most effective and efficient coordination of care and improve access and uptake of services?

    Recommendation ID NG66/3 Question Interventions for coordination and delivery of care to improve access and uptake:- What models for the

    Research recommendation
    Published
    16 May 2017

  2. Community-based models of flu vaccination:- What models of community-based flu vaccination provision (for example, community pharmacies, community nursing and midwifery teams and outreach services) are effective and cost-effective for increasing uptake in eligible groups?

    Recommendation ID NG103/5 Question Community-based models of flu vaccination:- What models of community-based flu vaccination provision

    Research recommendation
    Published
    12 December 2018

  3. What models of cross-organisational working improve clinical and cost effectiveness in relation to the suboptimal prescribing of medicines – for example, between NHS and social care, or primary and secondary care, or between NHS and commercial organisations?

    Recommendation ID NG5/4 Question What models of cross-organisational working improve clinical and cost effectiveness in relation to the

    Research recommendation
    Published
    10 August 2015

  4. Models of person-centred support:- What models of delivering person-centred support are effective and cost effective for people with a learning disability and behaviour that challenges, and their families and carers?What are the views and experiences of people with a learning disability and behaviour that challenges and their family members and carers, of different models of delivering person-centred support?

    Recommendation ID NG93/1 Question Models of person-centred support:- What models of delivering person-centred support are effective and

    Research recommendation
    Published
    15 November 2018

  5. Timing of pre-emptive transplant:- What is the most clinical and cost-effective strategy for timing of pre-emptive transplantation?

    Recommendation ID NG107/2 Question Timing of pre-emptive transplant:- What is the most clinical and cost-effective strategy for timing

    Research recommendation
    Published
    18 December 2018

  6. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    Recommendation ID CG181/2 Question What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can

    Research recommendation
    Published
    9 June 2015

  7. Interventions: What is the most clinically and cost‑effective management strategy for adults with calcific mitral stenosis and an indication for intervention?

    Recommendation ID NG208/21 Question Interventions: What is the most clinically and cost‑effective management strategy for adults with calcific

    Research recommendation
    Published
    16 December 2021

  8. What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK? (Demographic variables might include whether someone is an outdoor or indoor worker, their skin type and socioeconomic status.)

    Recommendation ID PH32/1 Question What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK

    Research recommendation
    Published
    9 June 2015

  9. Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects with antibiotics used to prevent or treat early-onset neonatal infection?

    Recommendation ID NG195/13 Question Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects

    Research recommendation
    Published
    6 August 2021

  10. Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management strategy for adults with tricuspid regurgitation?

    Recommendation ID NG208/02 Question Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management

    Research recommendation
    Published
    16 December 2021

  11. Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance to commonly used antibiotics among bacteria that cause early-onset neonatal infection?

    Recommendation ID NG195/11 Question Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance

    Research recommendation
    Published
    6 August 2021

  12. Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal fluid drainage or diversion (for example shunt surgery, external ventricular drain surgery or lumbar drain) for symptomatic acute hydrocephalus?

    Recommendation ID NG228/07 Question Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal

    Research recommendation
    Published
    12 December 2022

  13. What is the incidence of lentigo maligna diagnosed in England and which different therapies are used to treat lentigo maligna?

    Recommendation ID DG19/5 Question What is the incidence of lentigo maligna diagnosed in England and which different therapies are used

    Research recommendation
    Published
    12 January 2016

  14. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis, mitral regurgitation or tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/19 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  15. Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular osteoporosis, cardiovascular disease (CVD) and metabolic syndrome, in people with spondyloarthritis, and how does this compare with the general population? Are any specific spondyloarthritis features or risk factors associated with the incidence and outcomes of these complications?

    Recommendation ID NG65/2 Question Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular

    Research recommendation
    Published
    4 May 2017